Preferred Label : benralizumab;

MeSH note : a humanized mAb to IL-5Ralpha for the treatment of asthma;

MeSH hyponym : MEDI 563;

Is substance : O;

UNII : 71492GE1FX;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3539117/fr/fasenra-benralizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
benralizumab
chronic disease
biological therapy

---
https://www.has-sante.fr/jcms/p_3537837/fr/fasenra-benralizumab-granulomatose-eosinophilique
2024
France
evaluation of the transparency committee
Eosinophilia
Granulomatosis
Benralizumab
eosinophils
benralizumab
eosinophilia, nos
eosinophilia
Fasenra
eosinophil
Eosinophilia, CTCAE
Eosinophil
Eosinophil Count
granulomatosis, nos

---
https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma

---
https://ansm.sante.fr/tableau-acces-derogatoire/fasenra
2024
false
false
false
France
French
benralizumab
drug information

---
https://www.has-sante.fr/jcms/p_3419167/fr/fasenra-benralizumab-asthme
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
Eosinophilic asthma
eosinophilia
benralizumab
adult
injections, subcutaneous
evaluation of the transparency committee
benralizumab
asthma

---
https://www.has-sante.fr/jcms/c_2804050/fr/fasenra-benralizumab-et-nucala-mepolizumab-dans-le-traitement-de-l-asthme-severe
2019
false
false
false
France
French
asthma
eosinophilia
benralizumab
benralizumab
mepolizumab
health technology assessment
mepolizumab
Eosinophilic asthma
adult
adolescent
child
drug therapy, combination
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/jcms/p_3135589/fr/fasenra
2019
false
false
false
France
French
insurance, health, reimbursement
treatment outcome
benralizumab
Eosinophilic asthma
asthma
eosinophilia
benralizumab
injections, subcutaneous
evaluation of the transparency committee
antibodies, monoclonal, humanized

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00390
2018
false
false
false
Canada
French
English
drug information
benralizumab
antibodies, monoclonal, humanized

---
https://www.ema.europa.eu/medicines/human/EPAR/Fasenra
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
benralizumab
benralizumab
drug approval
europe
treatment outcome
asthma
Eosinophilic asthma
pulmonary eosinophilia
Prefilled Syringe Dosage Form
injections, subcutaneous
interleukin-5 receptor alpha subunit
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical
benralizumab
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/portail/jcms/c_2872645/fr/fasenra
2018
false
false
false
France
French
benralizumab
treatment outcome
asthma
Eosinophilic asthma
pulmonary eosinophilia
injections, subcutaneous
interleukin-5 receptor alpha subunit
evaluation of the transparency committee
adult
benralizumab
antibodies, monoclonal, humanized

---
http://www.cochrane.org/fr/CD010834/les-therapies-anti-il5-pour-le-traitement-de-lasthme
2017
false
false
false
false
France
United Kingdom
French
review of literature
adult
child
asthma
mepolizumab
mepolizumab
french abstract
mepolizumab
antibodies, monoclonal, humanized
reslizumab
benralizumab
Childhood asthma (disorder)

---
Nous contacter.
25/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.